172 related articles for article (PubMed ID: 18629495)
1. NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy.
Gao JQ; Tsuda Y; Han M; Xu DH; Kanagawa N; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
Cancer Immunol Immunother; 2009 Feb; 58(2):291-9. PubMed ID: 18629495
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressive efficacy through augmentation of tumor-infiltrating immune cells by intratumoral injection of chemokine-expressing adenoviral vector.
Okada N; Sasaki A; Niwa M; Okada Y; Hatanaka Y; Tani Y; Mizuguchi H; Nakagawa S; Fujita T; Yamamoto A
Cancer Gene Ther; 2006 Apr; 13(4):393-405. PubMed ID: 16224496
[TBL] [Abstract][Full Text] [Related]
3. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
Gao JQ; Kanagawa N; Motomura Y; Yanagawa T; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
Gene Ther; 2007 Mar; 14(6):491-502. PubMed ID: 17203106
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector.
Gao JQ; Tsuda Y; Katayama K; Nakayama T; Hatanaka Y; Tani Y; Mizuguchi H; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
Cancer Res; 2003 Aug; 63(15):4420-5. PubMed ID: 12907614
[TBL] [Abstract][Full Text] [Related]
5. Optimization of antitumor efficacy and safety of in vivo cytokine gene therapy using RGD fiber-mutant adenovirus vector for preexisting murine melanoma.
Okada Y; Okada N; Mizuguchi H; Takahashi K; Hayakawa T; Mayumi T; Mizuno N
Biochim Biophys Acta; 2004 Feb; 1670(3):172-80. PubMed ID: 14980444
[TBL] [Abstract][Full Text] [Related]
6. Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses.
Gao JQ; Kanagawa N; Xu DH; Han M; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
Cancer Immunol Immunother; 2008 Nov; 57(11):1657-64. PubMed ID: 18327579
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
[TBL] [Abstract][Full Text] [Related]
8. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.
Kanagawa N; Gao JQ; Motomura Y; Yanagawa T; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
Biochem Biophys Res Commun; 2008 Aug; 372(4):821-5. PubMed ID: 18519033
[TBL] [Abstract][Full Text] [Related]
9. A single intratumoral injection of a fiber-mutant adenoviral vector encoding interleukin 12 induces remarkable anti-tumor and anti-metastatic activity in mice with Meth-A fibrosarcoma.
Gao JQ; Sugita T; Kanagawa N; Iida K; Eto Y; Motomura Y; Mizuguchi H; Tsutsumi Y; Hayakawa T; Mayumi T; Nakagawa S
Biochem Biophys Res Commun; 2005 Mar; 328(4):1043-50. PubMed ID: 15707983
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy.
Narvaiza I; Mazzolini G; Barajas M; Duarte M; Zaratiegui M; Qian C; Melero I; Prieto J
J Immunol; 2000 Mar; 164(6):3112-22. PubMed ID: 10706701
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
[TBL] [Abstract][Full Text] [Related]
12. CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma.
Kanagawa N; Niwa M; Hatanaka Y; Tani Y; Nakagawa S; Fujita T; Yamamoto A; Okada N
Int J Cancer; 2007 Nov; 121(9):2013-2022. PubMed ID: 17621629
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor responses induced by chemokine CCL19 transfected into an ovarian carcinoma model via fiber-mutant adenovirus vector.
Gao JQ; Sugita T; Kanagawa N; Iida K; Okada N; Mizuguchi H; Nakayama T; Hayakawa T; Yoshie O; Tsutsumi Y; Mayumi T; Nakagawa S
Biol Pharm Bull; 2005 Jun; 28(6):1066-70. PubMed ID: 15930746
[TBL] [Abstract][Full Text] [Related]
14. The role of natural killer cells in adenovirus-mediated p53 gene therapy.
Carroll JL; Nielsen LL; Pruett SB; Mathis JM
Mol Cancer Ther; 2001 Nov; 1(1):49-60. PubMed ID: 12467238
[TBL] [Abstract][Full Text] [Related]
15. Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation.
Pan PY; Gu P; Li Q; Xu D; Weber K; Chen SH
J Immunol; 2004 Apr; 172(8):4779-89. PubMed ID: 15067054
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1.
Hasegawa K; Tagawa M; Takagi K; Tsukamoto H; Tomioka Y; Suzuki T; Nishioka Y; Ohrui T; Numasaki M
Cancer Gene Ther; 2016 Aug; 23(8):266-77. PubMed ID: 27561689
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
[TBL] [Abstract][Full Text] [Related]
19. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the anti-tumor activity of native, secreted, and membrane-bound LIGHT in mouse tumor models.
Morishige T; Yoshioka Y; Tanabe A; Yao X; Mizuguchi H; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
Int Immunopharmacol; 2010 Jan; 10(1):26-33. PubMed ID: 19800994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
